Nicox S.A. (OTCMKTS:NICXF) Sees Significant Decrease in Short Interest

Nicox S.A. (OTCMKTS:NICXF) was the target of a significant drop in short interest during the month of October. As of October 15th, there was short interest totalling 129,700 shares, a drop of 18.2% from the September 30th total of 158,600 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

Nicox Stock Performance

NICXF remained flat at $0.44 during midday trading on Wednesday. Nicox has a 52-week low of $0.44 and a 52-week high of $0.44. The stock’s fifty day moving average price is $0.44 and its two-hundred day moving average price is $0.44.

About Nicox

Nicox SA operates as an ophthalmology company in France and internationally. The company develops solutions to maintain vision and improve ocular health. Its lead product candidate is NCX 470, a novel nitric oxide-donating bimatoprost eye drop for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, which is in Phase 3 clinical trial.